510(k) Report

510(k) · Cleared

Cleared

Oculight GL/GLX

K050562510(k) TraditionalCleared Apr 14, 200542-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Iridex Corp · GEX Powered Laser Surgical Instrument

Cleared on Apr 14, 2005 as substantially equivalent to K022327 (Lumenis, Inc., 2002) after a 42-day review. Its family tree reaches back 1 generation to 2002. 75 later devices descend from it.

Decided
Apr 14, 2005
Review
42 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K022327 (2002). 75 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2006: 2 descendants cleared2009: 1 descendant cleared2011: 4 descendants cleared2010: 2 descendants cleared2022: 6 descendants cleared2015: 3 descendants cleared2016: 8 descendants cleared2024: 9 descendants cleared2013: 7 descendants cleared2014: 4 descendants cleared2026: 3 descendants cleared2025: 13 descendants cleared2020: 2 descendants cleared2019: 1 descendant cleared2018: 2 descendants cleared2012: 1 descendant cleared2023: 3 descendants cleared2021: 2 descendants cleared2017: 2 descendants clearedK022327 · Novus Spectra · Lumenis, Inc. · 2002200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 1 descendant3 generations forward: 2 descendants4 generations forward: 16 descendants5 generations forward: 19 descendants6 generations forward: 10 descendants7 generations forward: 6 descendants8 generations forward: 9 descendants9 generations forward: 6 descendants10 generations forward: 3 descendants11 generations forward: 1 descendant K022327 · Novus Spectra · Lumenis, Inc. · 20020+5+10
  1. Root · 1 generation backK022327 Novus SpectraLumenis, Inc. · 2002
  2. This deviceK050562 Oculight GL/GLXIridex Corp · 2005
  3. Descendant · cites it directly · 73 of its ownK062369 Iridex Oculight TXIridex Corp · 2006
  4. Descendant · 2 generations on · 72 of its ownK091534 Lightlas Model 532Lightmed Corp. · 2009
  5. Descendant · 3 generations on · 68 of its ownK100558 Quanta Diode Laser SystemQuanta System Spa · 2010
  6. Descendant · 4 generations on · 46 of its ownK102755 Ceralas E/ 1470NM Fiber-Coupled Diode Laser Family; Crealas HPD…Biolitec, Inc. · 2010
  7. Descendant · 5 generations on · 26 of its ownK110080 Radial-Emitting Shaped Fiber Optic Delivery SystemBiolitec, Inc. · 2011

Showing 5 of 75 descendants. See all descendants

Descendants cleared per year

2006: 22009: 12010: 22011: 42012: 12013: 72014: 42015: 32016: 82017: 22018: 22019: 12020: 22021: 22022: 62023: 32024: 92025: 132026: 3
2006high 13 (2025) · low 0 (2007)2026

Most influential descendants

Showing 5 of 75 · See all
  • K062369Iridex Oculight TXIridex Corp · 2006 · cites it directly73descendants
  • K091534Lightlas Model 532Lightmed Corp. · 2009 · 2 generations on72descendants
  • K100558Quanta Diode Laser SystemQuanta System Spa · 2010 · 3 generations on68descendants
  • K102755Ceralas E/ 1470NM Fiber-Coupled Diode Laser Family; Crealas HPD Multiwavelenght 980NM/…Biolitec, Inc. · 2010 · 4 generations on46descendants
  • K110080Radial-Emitting Shaped Fiber Optic Delivery SystemBiolitec, Inc. · 2011 · 5 generations on26descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K022327Novus SpectraLumenis, Inc.2002—
0 (this device)K050562Oculight GL/GLXIridex Corp2005—
+1K062369Iridex Oculight TXIridex Corp2006—
+2K091534Lightlas Model 532Lightmed Corp.2009—
+3K100558Quanta Diode Laser SystemQuanta System Spa2010—
+4K102755Ceralas E/ 1470NM Fiber-Coupled Diode Laser Family; Crealas HPD…Biolitec, Inc.2010—
+5K110080Radial-Emitting Shaped Fiber Optic Delivery SystemBiolitec, Inc.2011—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200620
200910
201020
201140
201210
201370
201440
201530
201680
201720
201820
201910
202020
202120
202260
202330
202490
2025130
202630
FIG. 1 — Lineage of K050562, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022327Novus Spectra
Summary page 1
…systems are substantially equivalent to other currently legally marketed ophthalmology laser devices including OeLi~SY`LAa" systems and the Lumenis Novus Spectra (K022327). Device Description The OcuLight GIJGLx is a semiconductor-based laser that delivers true continuous wave green laser…
Lumenis, Inc.2002—
*—OcuLight SL/SLx Laser Systems
Named without a submission number
—

Also cleared against K022327: 6 other devices →

What descends from it? (75)

See all 75

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K062369Iridex Oculight TXIridex Corp200673
K062074Iridex Wireless FootswitchIridex Corp20060

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K062369 (Iridex Corp, 2006) has gone furthest, with 73 descendants of its own.
  • 6 other devices also cite its predicate K022327.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The IRIDEX OcuLight GL/GLx is used in ophthalmic, dermatology, and ear nose and throat (ENT) applications. Specific indications are listed below: Condition: Diabetic Retinopathy * Nonproliferative Retinopathy * Macular Edema * Proliferative Retinopathy Treatment: Retinal Photocoagulation (RPC); Focal and Grid Laser Treatments Condition: Glaucoma * Primary Open Angle * Closed Angle Treatment: Laser Trabeculoplasty; Iridotomy, Iridoplasty Condition…

Read the full statement (193 words)

The IRIDEX OcuLight GL/GLx is used in ophthalmic, dermatology, and ear nose and throat (ENT) applications. Specific indications are listed below:

Condition: Diabetic Retinopathy

* Nonproliferative Retinopathy

* Macular Edema

* Proliferative Retinopathy

Treatment: Retinal Photocoagulation (RPC); Focal and Grid Laser Treatments

Condition: Glaucoma

* Primary Open Angle

* Closed Angle

Treatment: Laser Trabeculoplasty; Iridotomy, Iridoplasty

Condition: Retinal Tears and Detachments

Treatment: RPC; Focal and Grid Laser Treatments

Condition: Lattice Degeneration

Treatment: RPC; Focal and Grid Laser Treatments

Condition: Age-related Macular Degeneration (AMD)

Treatment: RPC; Focal and Grid Laser Treatments

Condition: Intra-Ocular Tumors

* Choroidal Hemangioma

* Choroidal Melanoma

* Retinoblastoma

Treatment: RPC; Focal and Grid Laser Treatments

Condition: Retinopathy of Prematurity

Treatment: RPC; Focal and Grid Laser Treatments

Condition: Sub-Retinal (choroidal) Neovascularization

Treatment: RPC; Focal and Grid Laser Treatments

Condition: Central and Branch Retinal Vein Occlusion

Treatment: RPC; Focal and Grid Laser Treatments

Condition: Dermatology

* Pigmented Skin Lesions

* Vascular lesions

Treatment: Focal Laser Treatments

Condition: Ear, Nose and Throat

* Otosclerotic hearing loss and/or diseases of the inner ear

Treatment: Stapedectomy; Stapedotomy; Myringotomies; Lysis of Adhesions; Control of Bleeding; Removal of Acoustic Neuromas; Soft tissue Adhesion in Micro/Macro Otologic Procedures

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K050562: Oculight GL/GLX.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K050562

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026